Citadel Advisors - SQZ BIOTECHNOLOGIES CO ownership

SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 50 filers reported holding SQZ BIOTECHNOLOGIES CO in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SQZ BIOTECHNOLOGIES CO
ValueSharesWeighting
Q1 2023$8,680
-77.2%
15,500
-8.2%
0.00%
Q3 2022$38,000
-81.1%
16,891
-73.3%
0.00%
Q2 2022$201,000
+44.6%
63,241
+118.0%
0.00%
Q1 2022$139,000
+31.1%
29,013
+145.0%
0.00%
Q4 2021$106,000
-35.4%
11,844
+3.9%
0.00%
Q3 2021$164,00011,4000.00%
Other shareholders
SQZ BIOTECHNOLOGIES CO shareholders Q4 2021
NameSharesValueWeighting ↓
NanoDimension, Inc. 1,445,221$6,952,00015.25%
683 Capital Management, LLC 2,098,815$10,096,0000.54%
Artal Group S.A. 1,606,309$7,726,0000.32%
Sandy Cove Advisors, LLC 51,707$249,0000.21%
MAVERICK CAPITAL LTD 1,056,786$5,083,0000.09%
ACT CAPITAL MANAGEMENT, LLC 16,000$77,0000.08%
AMERICAN INTERNATIONAL GROUP, INC. 2,528,477$12,162,0000.07%
Temasek Holdings (Private) Ltd 2,758,169$13,266,7930.06%
Alphabet Inc. 103,929$500,0000.02%
Baldrige Asset Management LLC 5,000$24,0000.01%
View complete list of SQZ BIOTECHNOLOGIES CO shareholders